Arvinas, Inc. (ARVN)
8.29
-0.02
(-0.24%)
USD |
NASDAQ |
Sep 18, 16:00
8.275
-0.02
(-0.18%)
Pre-Market: 20:00
Arvinas Cash from Investing (Quarterly) : 54.90M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.90M |
| March 31, 2026 | 13.70M |
| December 31, 2025 | 145.80M |
| September 30, 2025 | 63.50M |
| June 30, 2025 | 128.80M |
| March 31, 2025 | 69.50M |
| December 31, 2024 | 98.90M |
| September 30, 2024 | 50.50M |
| June 30, 2024 | 13.10M |
| March 31, 2024 | -127.80M |
| December 31, 2023 | -53.70M |
| September 30, 2023 | 70.00M |
| June 30, 2023 | 48.60M |
| March 31, 2023 | 138.60M |
| December 31, 2022 | 19.40M |
| September 30, 2022 | 105.80M |
| June 30, 2022 | 109.00M |
| March 31, 2022 | 8.60M |
| December 31, 2021 | -115.63M |
| Date | Value |
|---|---|
| September 30, 2021 | -741.10M |
| June 30, 2021 | -249.05M |
| March 31, 2021 | -207.82M |
| December 31, 2020 | 56.86M |
| September 30, 2020 | 59.28M |
| June 30, 2020 | 5.610M |
| March 31, 2020 | 42.49M |
| December 31, 2019 | -95.43M |
| September 30, 2019 | -31.81M |
| June 30, 2019 | -4.228M |
| March 31, 2019 | 38.37M |
| December 31, 2018 | -101.86M |
| September 30, 2018 | 11.80M |
| June 30, 2018 | -45.26M |
| March 31, 2018 | -44.34M |
| December 31, 2017 | 0.3395M |
| September 30, 2017 | 6.927M |
| June 30, 2017 | 11.09M |
| March 31, 2017 | 2.515M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 0.00 |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Fulcrum Therapeutics, Inc. | 13.78M |
| Definium Therapeutics, Inc. | -315.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.30M |
| Cash from Financing (Quarterly) | 0.40M |
| Free Cash Flow | -208.80M |
| Free Cash Flow Per Share (Quarterly) | -0.7382 |
| Free Cash Flow to Equity (Quarterly) | -48.10M |
| Free Cash Flow to Firm (Quarterly) | -48.50M |
| Free Cash Flow Yield | -37.62% |